factual
Delivery reduces to getting nucleic acids into any cell type
The delivery problem for genetic medicines can be reduced to getting nucleic acids into any desired cell type specifically, since nucleic acids can drug anything in the genome; current modalities are lipid nanoparticles (fat bubbles defaulting to liver, tunable via attached antibodies) and viral vectors like AAV (limited packaging size), and sequence engineering can only add NOT gates to narrow delivery, never expand it to cells not initially reached.
factualpending
Speaker
Jacob KimmelEvidence Quote
“You can start broad with your delivery vector and then use sequence to narrow down to make it more specific, but not the other way around.”
Created: 6/13/2026, 3:28:32 AM
Your notes
Loading notes...